Researchers investigate systemic proteome adaptations to one week of fasting in humans.
Optimi Health to Supply GMP-Certified Psilocybin for Psyence Biomed’s Phase IIb Palliative Care Trial | Psychedelic Invest
Vancouver, British Columbia–(Newsfile Corp. – December 17, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a Canadian manufacturer